SEC Form 4 · accession 0001209191-17-016829
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rajinder Singh
Officer — SVP, Research
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 5:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $6.62 | Feb 28, 2017 | A | 80,000 | A | — | Feb 28, 2027 | Common Stock | 80,000 | 80,000 | D |
| Restricted Stock UnitsF2,F3,F4 | — | Feb 28, 2017 | A | 30,000 | A | — | — | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The option was granted on February 28, 2017. 25% of the total number of shares of common stock subject to the option will vest on January 1, 2018, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- F2Not applicable.
- F3Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F4The restricted stock units vest in three equal installments on January 1, 2018, January 1, 2019, and January 1, 2020, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.